The drug, called GIGA-2050, uses a new approach similar to treating COVID-19 patients with convalescent plasma.
They are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent the disease.
To help physicians choose the best antibiotic first, researchers in the School of Pharmacy and the State Cartographer's Office are drawing inspiration from the weather.
An increase in the proportion of the population that is undocumented is associated with fewer drug arrests, drunken driving arrests and drug overdoses.
The Precision Medicine Molecular Tumor Board has a dual mission: consulting with oncologists statewide about targeted drugs to battle out-of-control cancers; and amassing data on what works and what does not.
The new method gives chemists prospecting for bioactive molecules a new tool in the search for novel drugs or chemicals for agriculture.
Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront of drug discovery. So drug companies want a faster route to step one: identifying which of the millions of possible antibodies will work against molecules that cause disease.